Hydrocodone and codeine are not the same drug. They belong to the same family of opioid painkillers and share some overlapping uses, but they differ in origin, strength, how your body processes them, and how tightly they’re regulated. Hydrocodone is roughly six to seven times more potent than codeine on a milligram-for-milligram basis, which is one of the most practical differences between the two.
How They Differ Chemically
Codeine is a natural alkaloid extracted directly from the opium poppy plant. It’s one of the oldest painkillers still in use and is generally considered a milder opioid. Hydrocodone, by contrast, is semi-synthetic. It’s manufactured by chemically modifying codeine or another natural opiate in a lab, which changes its properties enough to make it a distinctly different medication with stronger effects.
Potency: The Biggest Practical Difference
The standard way to compare opioid strength is to convert each drug into morphine milligram equivalents (MME). Using this system, codeine has a conversion factor of 0.15, while hydrocodone has a conversion factor of 1. That means 10 mg of hydrocodone is equivalent to about 10 mg of morphine, while 10 mg of codeine is equivalent to only 1.5 mg of morphine. Put another way, you’d need roughly 67 mg of codeine to match the pain-relieving effect of 10 mg of hydrocodone.
This potency gap is why the two drugs are prescribed for different levels of pain. Hydrocodone is primarily used for severe chronic pain that isn’t adequately controlled by non-opioid options. Codeine is reserved for mild to moderate pain. Both are also used as cough suppressants, though the FDA restricted prescription cough medicines containing either drug to adults 18 and older starting in 2018.
How Your Body Processes Each One
Both drugs depend on the same liver enzyme, called CYP2D6, to be converted into their active forms. This is where things get interesting, because the two drugs follow different metabolic paths once they enter your body.
Codeine is technically a prodrug. It has very little painkilling power on its own. Your liver must convert it into morphine before it can relieve pain. If you happen to be someone whose body produces less of the CYP2D6 enzyme (known as a “poor metabolizer”), codeine may barely work for you because your body can’t efficiently turn it into morphine. On the other end of the spectrum, people who are rapid metabolizers convert codeine into morphine faster than normal, which can produce unexpectedly strong effects or even dangerous side effects from a standard dose.
Hydrocodone also relies on CYP2D6, which converts it into a more potent compound called hydromorphone. However, hydrocodone itself has meaningful painkilling activity before that conversion happens, so poor metabolizers are more likely to still get some relief from it compared to codeine. That said, genetic variations in this enzyme can still reduce hydrocodone’s effectiveness for some people.
Because both drugs funnel through the same enzyme, your individual genetics play a surprisingly large role in how well either medication works for you. This is one reason a doctor might switch someone from one opioid to another if the first isn’t providing adequate relief.
Onset and Duration
Immediate-release hydrocodone typically begins working within 10 to 15 minutes, reaches peak effect at 30 to 60 minutes, and lasts 3 to 6 hours. Codeine follows a similar general timeline but tends to have a slightly slower onset because of the extra metabolic step required to convert it into morphine. Both drugs are available in immediate-release and extended-release formulations, though extended-release hydrocodone products are more commonly prescribed for around-the-clock pain management.
Common Formulations
You’ll rarely find either drug sold alone. Both are typically combined with other ingredients, and the combination product you’re prescribed tells you a lot about what it’s being used for.
Hydrocodone is most commonly paired with acetaminophen in products like Vicodin, Norco, and Lortab. It’s also available combined with ibuprofen (Vicoprofen) and with antihistamines or decongestants in cough and cold formulations like Tussionex. Codeine follows a similar pattern: it’s combined with acetaminophen in Tylenol with Codeine and with promethazine or guaifenesin in various cough syrups.
Legal Classification
Both drugs are controlled substances, but their scheduling differs depending on the formulation, reflecting their different abuse potentials.
- Hydrocodone: All hydrocodone products are Schedule II, the most restrictive category for drugs with accepted medical use. This means no refills on prescriptions, and a new prescription is required each time.
- Codeine in pure form: Also Schedule II.
- Codeine combination products: Here’s where the distinction matters. Products containing up to 90 mg of codeine per dose (like Tylenol with Codeine) drop to Schedule III, and cough preparations with small amounts of codeine (like Robitussin AC) are Schedule V, the least restrictive category.
This tiered scheduling for codeine reflects its lower potency and abuse potential compared to hydrocodone. In practical terms, it means codeine combination products are somewhat easier to prescribe and, in some states, certain low-dose codeine cough syrups can be dispensed with fewer restrictions.
Side Effects and Risks
The side effect profiles overlap considerably. Both can cause drowsiness, constipation, nausea, dizziness, and respiratory depression (slowed breathing). Both carry a risk of dependence and addiction with prolonged use. The key difference is that hydrocodone’s greater potency means these risks are generally more pronounced at equivalent pain-relieving doses. Respiratory depression, the most dangerous opioid side effect, is dose-dependent, so stronger opioids require more careful monitoring.
Codeine carries its own unique risk related to the metabolizer issue described above. Rapid metabolizers can experience life-threatening respiratory depression from standard codeine doses because their bodies flood themselves with morphine too quickly. This risk is especially concerning in children, which is one reason codeine use in pediatric patients has been sharply curtailed in recent years.